Orthofix Medical Inc.

OFIX

US68752M1080

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-23 EDT			5-day change	1st Jan Change
14.87 ^USD	+2.06%		-1.59%	+10.31%

05-23	Orthofix Medical Inc. Appoints Max Reinhardt as President of Global Spine Business Effective June 10, 2024	CI
05-09	Orthofix Medical Inc. Announces FDA 510(K) Clearance for the Rodeo Telescopic Nail	CI

Orthofix Medical Inc. Provides Net Sales Guidance for the Year Ended December 31, 2022

May 06, 2022 at 07:57 am

Orthofix Medical Inc. provided net sales guidance for the year ended December 31, 2022. For the year, company expects net sales to be $475.0 million to $490.0 million.

Latest news about Orthofix Medical Inc.

Orthofix Medical Inc. Appoints Max Reinhardt as President of Global Spine Business Effective June 10, 2024	05-23	CI
Orthofix Medical Inc. Announces FDA 510(K) Clearance for the Rodeo Telescopic Nail	05-09	CI
Roth MKM Upgrades Orthofix Medical to Buy From Neutral With $20 Price Target	05-08	MT
Transcript : Orthofix Medical Inc., Q1 2024 Earnings Call, May 07, 2024	05-07
Earnings Flash (OFIX) ORTHOFIX MEDICAL Reports Q1 Revenue $188.6M	05-07	MT
Orthofix Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-07	CI
Orthofix Medical Inc. Revises Earnings Guidance for the Year 2024	05-07	CI
Orthofix Medical Inc. Appoints Andres Cedron as New Chief Legal Officer	04-16	CI
Orthofix Medical Inc. Announces Board Resignation	04-12	CI
Orthofix Medical Inc. Appoints Lucas Vitale as Chief People and Business Operations Officer	03-18	CI
Orthofix Medical Q4 Loss Widens, Sales Rise; 2024 Sales Outlook Set	03-05	MT
Orthofix Medical Inc. Provides Revenue Guidance for the First Quarter, Second Quarter and Third Quarter of 2024	03-05	CI
Transcript : Orthofix Medical Inc., Q4 2023 Earnings Call, Mar 05, 2024	03-05
Orthofix Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-05	CI
Earnings Flash (OFIX) ORTHOFIX MEDICAL Reports Q4 Revenue $200.4M, vs. Street Est of $195.6M	03-05	MT
Orthofix Medical Guides For 2024 Sales of $785-$795 Million, vs CIQ Analyst Consensus of $799 Million	03-05	MT
Orthofix Medical Inc. Provides Earnings Guidance for the Year 2024	03-05	CI
Orthofix Medical Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-05	CI
Orthofixan Signs Deal to Distribute BoneMRI Imaging Software in US	01-18	MT
Orthofix Announces Commercial Partnership with MRIguidance	01-18	CI
Earnings Flash (OFIX) ORTHOFIX MEDICAL Posts Q4 Revenue $200.3M	01-09	MT
Orthofix Medical Inc. Names Massimo Calafiore as President and Member of the Board of Directors Effective Immediately	01-08	CI
Orthofix Medical Inc. Names Massimo Calafiore as Chief Executive Officer	01-08	CI
Orthofix Medical Inc. Appoints Julie Andrews as Chief Financial Officer	01-08	CI
Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis	12-21	CI

Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions specifically related to limb reconstruction and deformity correction unrelated to the spine. Global Orthopedics distributes its products globally through a network of distributors and sales representatives to sell orthopedic products to hospitals and healthcare providers. It has a portfolio of biologics, spinal hardware, bone growth therapies, specialized orthopedic solutions, and surgical navigation system. Its products are distributed in 68 countries globally via the Company's sales representatives and distributors.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-06-18 - Annual General Meeting

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Orthofix Medical Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

14.87 USD

Average target price

20.13 USD

Spread / Average Target

+35.40%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ORTHOFIX MEDICAL INC.	+10.31%	547M
ABBOTT LABORATORIES	-5.31%	182B
MEDTRONIC PLC	-1.21%	114B
BECTON, DICKINSON AND COMPANY	-5.53%	67.76B
DEXCOM, INC.	+1.22%	51.91B
CENCORA, INC.	+7.03%	43.23B
HOYA CORPORATION	+5.19%	41.07B
METTLER-TOLEDO INTERNATIONAL, INC.	+21.96%	32.07B
TERUMO CORPORATION	+14.41%	25B
ZIMMER BIOMET HOLDINGS, INC.	-4.81%	24.55B

Other Medical Equipment, Supplies & Distribution